Article

Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells

2024-10-11

Abstract excerpt

Radiopharmaceutical therapy (RPT) has become an effective treatment option for neuroendocrine tumors (NETs) and castration-resistant prostate cancer and is in clinical development for a growing number of indications. One of the major advantages of theranostic RPT is that the distribution of radiopharmaceuticals in the human body can be imaged, and radiation doses to the patient’s organs can be calculated. However,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3edaf948-f9e5-5c1c-9bfb-643068748710
DOI: 10.1101/2024.10.07.615865

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cellsDOI 10.1101/2024.10.07.615865Read

Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cellsSemantic proximity Read

DNA-PKcs inhibitors sensitize neuroendocrine tumor cells to peptide receptor radionuclide therapy in vitro and in vivoSemantic proximity Read

Somatostatin Receptor Based Imaging and Radionuclide TherapySemantic proximity Read

Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer.Semantic proximity Read

Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Advanced Neuroendocrine Tumours (NETs) in a Limited Resource EnvironmentSemantic proximity Read

Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy.Semantic proximity Read

Understanding the Radiobiological Mechanisms Induced by 177Lu-DOTATATE in Comparison to External Beam Radiation TherapySemantic proximity Read

A pan-cancer analysis of the clinical and genetic portraits of somatostatin receptor expressing-tumor as a potential target of peptide receptor imaging and therapySemantic proximity Read

Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work BetterSemantic proximity Read

SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicitySemantic proximity Read

New Developments in Peptide Receptor Radionuclide TherapySemantic proximity Read

Radiosensitization of NET cells by HSP90 inhibitor ganetespib is mediated through pleiotropic stress responsesSemantic proximity Read